Literature DB >> 16703964

[Validating the Simpson-Angus Extrapyramidal Collateral Symptom Evaluation Scale].

José Manuel Calvo-Gómez1, Ricardo Sánchez-Pedraza, Luis Eduardo Jaramillo-González, Carlos Tarcisio-Mantilla.   

Abstract

OBJECTIVES: The study was aimed at validating the Simpson-Angus scale for neuroleptic-induced extrapyramidal syndrome in Colombia, using a Spanish version of the scale.
METHODS: The scale was validated in four steps: translating the scale, pilot study, preliminary use for factorial analysis and analysis of validity, reliability and sensitivity to change.
RESULTS: Factorial structure and internal consistency were evaluated in 86 psychiatric inpatients. Test-retest and inter-rater reliability were evaluated in a 15-patient subgroup. Concurrent validity was analysed by simultaneously applying Simpson-Angus and Chouinard scales. Sensitivity to change was evaluated by comparing the scores of two different clinical points in a 20-patient subgroup. Main factor analysis revealed that the scale has a one-dimensional structure; the Glabella tap did not contribute towards total variability of the condition measured for the scale. Test-retest and inter-rater reliability values, concurrent validity and sensitivity to change were good. Correlation estimation scores were above 0.8 and accuracy levels were also good.
CONCLUSIONS: The Spanish version of the SA scale, adapted for this study, is suitable for assessing neuroleptic-induced extrapyramidal syndrome; it would be a useful instrument in both clinical practice and research settings in Colombia. However, an important limitation could be its lack of detecting any domain different to that of rigidity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16703964     DOI: 10.1590/s0124-00642006000100007

Source DB:  PubMed          Journal:  Rev Salud Publica (Bogota)        ISSN: 0124-0064


  2 in total

1.  Spontaneous parkinsonism is associated with cognitive impairment in antipsychotic-naive patients with first-episode psychosis: a 6-month follow-up study.

Authors:  Manuel J Cuesta; Ana M Sánchez-Torres; Elena García de Jalón; Maria S Campos; Berta Ibáñez; Lucía Moreno-Izco; Víctor Peralta
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

2.  Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study.

Authors:  Wenjuan Yu; Jingjing Huang; Sidi He; Lei Zhang; Yifeng Shen; Huafang Li
Journal:  Gen Psychiatr       Date:  2021-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.